Independent roles of macrophage migration inhibitory factor and endogenous, but not exogenous glucocorticoids in regulating leukocyte trafficking

Microcirculation

Volumn 16, Issue 8, 2009, Pages 735-748

  Gregory, Julia L ^a   Hall, Pam ^a   Leech, Michelle ^a   Morand, Eric F ^a   Hickey, Michael J ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Adhesionmolecules; Cell trafficking; Cytokines; Inflammation

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; DEXAMETHASONE; GLUCOCORTICOID; INTERCELLULAR ADHESION MOLECULE 1; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 2; MACROPHAGE MIGRATION INHIBITION FACTOR; MIFEPRISTONE; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN KC; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME REGULATION; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION;

ANIMALS; CELL ADHESION; CHEMOTAXIS, LEUKOCYTE; DEXAMETHASONE; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GLUCOCORTICOIDS; INFLAMMATION MEDIATORS; LEUKOCYTES; LIPOPOLYSACCHARIDES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MICE; MICE, KNOCKOUT;

MUS;

EID: 70350647303     PISSN: 10739688     EISSN: 15498719     Source Type: Journal    
DOI: 10.3109/10739680903210421     Document Type: Article

References (67)

1. Aeberli D, Yang YH, Mansell A, Santos L, Leech M, Morand EF. (2006). Endogenous macrophage migration inhibitory factor modulates glucocorticoid sensitivity in macrophages via effects on MAP kinase phosphatase-1 and p38 MAP kinase. FEBS Lett 580: 974-981.
2. Ajuebor MN, Gibbs L, Flower RJ, Das AM, Perretti M. (1998). Investigation of the functional role played by the chemokine monocyte chemoattractant protein-1 in interleukin-1-induced murine peritonitis. Br J Pharmacol 125:319-326.
3. Allcock GH, Allegra M, Flower RJ, Perretti M. (2001). Neutrophil accumulation induced by bacterial lipopolysaccharide: effects of dexamethasone and Annexin 1. Clin Exp Immunol 123:62-67.
4. Bernhagen J, Calandra T, Mitchell RA, Martin SB, Tracey KJ, Voelter W, et al. (1993 ). MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365:756-759. (Pubitemid 23339882)
5. Bernhagen J, Krohn R, Lue H, Gregory JL, Zernecke A, Koenen RR, et al. (2007). MIF is a noncognate ligand of CXC chemokine receptors in infl ammatory and atherogenic cell recruitment. Nat Med 13:587-596 .
6. Bozza M, Satoskar AR, Lin G, Lu B, Humbles AA, Gerard C, David JR. (1999). Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J Exp Med 189:341-346.
7. Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, Donnelly T, et al. (1995). MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377:68-71.
8. Calandra T, Bernhagen J, Mitchell RA, Bucala R. (1994). The macrophage is an important and previously unrecognised source of macrophage migration inhibitory factor. J Exp Med 179:1895-1902 . (Pubitemid 24155670)
9. Calandra T, Echtenacher B, Le Roy D, Pugin J, Metz CN, Hultner L, et al. (2000). Protection from septic shock by neutralization of macrophage inhibitory factor. Nat Med 6:164-170.
10. Castellani ML, Shanmugham LN, Petrarca C, Simeonidou I, Frydas S, De Colli M, et al. (2007). Expression and secretion of RANTES (CCL5) in granulomatous calcifi ed tissue before and after lipopolysaccharide treatment in vivo. Calcif Tissue Int 80:60-67.
11. Crinelli R, Antonelli A, Bianchi M, Gentilini L, Scaramucci S, Magnani M. (2000). Selective inhibition of NF-B activation and TNF-production in macrophages by red blood cell-mediated delivery of dexamethasone. Blood Cells Mol Dis 26:211-222.
12. Cronstein BN, Kimmel SC, Levin RI, Martiniuk F, Weissmann G.(1992). A mechanism for the anti-infl ammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc Natl Acad Sci U S A 89:9991-9995.
13. Davenpeck KL, Zagorski J, Schleimer R P, Bochner BS. (1998). Lipopolysaccharide-induced leukocyte rolling and adhesion in the rat mesenteric microcirculation: regulation by glucocorticoids and role of cytokines. J Immunol 161:6861-6870.
14. Denkinger CM, Denkinger M, Kort JJ, Metz C, Forsthuber TG. (2003). In vivo blockade of macrophage migration inhibitory factor ameliorates acute experimental autoimmune encephalomyelitis by impairing the homing of encephalitogenic T cells to the central nervous system. J Immunol 170:1274-1282.
15. Donnelly SC, Bucala R. (1997). Macrophage migration inhibitory factor: a regulator of glucocorticoid activity with a critical role in infl ammatory disease. Mol Med Today 3:502-507.
16. Farsky S P, Sannomiya P, Garcia-Leme J. (1995). Secreted glucocorticoids regulate leukocyte-endothelial interactions in infl ammation. A direct vital microscopic study. J Leukoc Biol 57:379-386.
17. Fingerle-Rowson G, Koch P, Bikoff R, Lin X, Metz CN, Dhabhar FS, et al. (2003). Regulation of macrophage migration inhibitory factor expression by glucocortocoids in vivo. Am J Pathol 162:47-56. (Pubitemid 36041989)
18. Fingerle-Rowson G, Petrenko O, Metz CN, Forsthuber TG, Mitchell R, Huss R, et al. (2003). The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting. Proc Natl Acad Sci U S A 100:9354-9359.
19. Flaster H, Bernhagen J, Calandra T, Bucala R. (2007). The macrophage migration inhibitory factor-glucocorticoid dyad: regulation of infl ammation and immunity. Mol Endocrinol 21:1267-1280.
20. Foote A, Brigante FM, Kipen Y, Santos L, Leech M, Morand EF. (2004). Macrophage migration inhibitory factor in systemic lupus erythematosus. J Rheumatol31:268-273. (Pubitemid 38160747)
21. Gregory JL, Leech MT, David J, Yang YH, Dacumos A, Hickey MJ. (2004). Reduced leukocyte-endothelial cell interactions in the infl amed microcirculation of macrophage migration inhibitory factor-defi cient mice. Arthr Rheum 50:3023-3034.
22. Gregory JL, Morand EF, McKeown SJ, Ralph JA, Hall P, Yang YH, et al. (2006). Macrophage migration inhibitory factor induces macrophage recruitment via CC chemokine ligand 2. J Immunol 177:8072-8079.
23. Heit B, Colarusso P, Kubes P. (2005). Fundamentally different roles for LFA-1, Mac-1, and 4 integrin in neutrophil chemotaxis. J Cell Sci 118:5205-5220.
24. Hermann C, von Aulock S, Dehus O, Keller M, Okigami H, Gantner F, et al. (2006). Endogenous cortisol determines the circadian rhythm of lipopolysaccharide- but not lipoteichoic acid-inducible cytokine release. Eur J Immunol 36:371-379.
25. Hirasawa N, Watanabe M, Mue S, Watanabe K, Tsurufuji S, Ohuchi K. (1992). Induction of neutrophil infi ltration by rat chemotactic cytokine (CINC) and its inhibition by dexamethasone in rats. Infl ammation 16:187-196.
26. Hoi AY, Hickey MJ, Hall P, Yamana J, O'Sullivan KM, Santos LL, et al. (2006). Macrophage migration inhibitory factor defi ciency attenuates macrophage recruitment, glomerulonephritis, and lethality in MRL/lpr mice. J Immunol 177:5687-5696.
27. Huang XR, Chun Hui CW, Chen YX, Wong BC, Fung PC, Metz C, et al. (2001). Macrophage migration inhibitory factor is an important mediator in the pathogenesis of gastric infl ammation in rats. Gastroenterology 121:619-630.
28. Kamiyama K, Matsuda N, Yamamoto S, Takano K, Takano Y, Yamazaki H, et al. (2008). Modulation of glucocorticoid receptor expression, infl ammation, and cell apoptosis in septic guinea pig lungs using methylprednisolone. Am J Physiol Lung Cell Mol Physio 295:L998-L1006.
29. Kawahara RS, Deng ZW, Deuel TF. (1991). PDGF and the small inducible gene (SIG) family: roles in the infl ammatory response. Adv Exp Med Biol 305: 79-87.
30. Lacey D, Sampey A, Mitchell RA, Bucala R, Santos L, Leech M, et al. (2003). Control of fi broblast-like synoviocyte proliferation by macrophage migration inhibitory factor. Arthr Rheum 48:103-109. (Pubitemid 36091654)
31. Lan HY, Yang N, Nikolic-Paterson DJ, Yu XQ, Mu W, Isbel NM, et al. (2000). Expression of macrophage migration inhibitory factor in human glomerulonephritis. Kidney Int 57:499-509.
32. Leech M, Huang XR, Morand EF, Holdsworth SR. (2000). Endogenous glucocorticoids modulate experimental antiglomerular basement membrane glomerulonephritis. Clin Exp Immunol 119:161-168.
33. Leech M, Hutchinson P, Holdsworth SR, Morand E F. (1998). Endogenous glucocorticoids modulate neutrophil migration and synovial P-selectin expression, but not neutrophil phagocytic or oxidative function, in experimental arthritis. Clin Exp Immunol 112:383-388.
34. Leech M, Metz CN, Hall P, Hutchinson P, Gianis K, Smith M, et al. (1999). Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinfl ammatory function and regulation by glucocorticoids. Arthr Rheum 42:1601-1608.
35. Leech M, Metz CN, Santos L, Peng T, Holdsworth SR, Bucala R, et al. (1998). Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis. Arthr Rheum 41:910-917. (Pubitemid 28225792)
36. Li L, Whiteman M, Moore PK. ( 2008). Dexamethasone inhibits lipopolysacharide-induced hydrogen sulfi de biosynthesis in intact cells and in an animal model of endotoxic shock. J Cell Mol Med Dec 16 [Epub ahead of print] .
37. Lin X, Sakuragi T, Metz CN, Ojamaa K, Skopicki HA, Wang P, et al. (2005). Macrophage migration inhibitory factor within the alveolar spaces induces changes in the heart during late experimental sepsis. Shock 24:556-563.
38. Lister KJ, James WG, Hickey MJ. (2007). Immune complexes mediate rapid alterations in microvascular permeability: roles for neutrophils, complement, and platelets. Microcirculation 14:709-722.
39. Marui N, Offermann MK, Swerlick R, Kunsch C, Rosen CA, Ahmad M, et al. (1993). Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest 92:1866-1874.
40. Mikulowska A, Metz CN, Bucala R, Holmdahl R. (1997). Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice. J Immunol 158:5514-5517.
41. Mitchell RA, Metz C, Peng T, Bucala R. (1999). Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF). J Biol Chem 274:18100-18106.
42. Moore SL, Fewell JE. (2006). Mifepristone (RU38486) infl uences the core temperature response of term pregnant rats to intraperitoneal lipopolysaccharide. Exp Physiol 91:741-746.
43. Morand EF, Leech M, Bernhagen J. (2006). MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis. Nat Rev Drug Discov 5:399-410.
44. Morand EF, Leech M, Weedon H, Metz C, Bucala R, Smith MD. (2002). Macrophage migration inhibitory factor in rheumatoid arthritis: clinical correlations. Rheumatology (Oxford). 41:558-562.
45. Mori N, Horie Y, Gerritsen ME, Anderson DC, Granger DN. (1999). Anti-infl ammatory drugs and endothelial cell adhesion molecule expression in murine vascular beds. Gut 44:186-195.
46. Mukaida N, Zachariae CCO, Gusella GL, Matsushima K. (1991). Dexamethasone inhibits the induction of monocyte chemotactic-activating factor production by IL-1 or tumor necrosis factor. J Immunol 146: 1212-1215.
47. Neeck G, Kluter A, Dotzlaw H, Eggert M. (2002). Involvement of the glucocorticoid receptor in the pathogenesis of rheumatoid arthritis. Ann N Y Acad Sci 966:491-495. (Pubitemid 34729211)
48. Norman MU, Lister KJ, Yang YH, Issekutz A, Hickey MJ. (2005). TNF regulates leukocyte-endothelial cell interactions and microvascular dysfunction during immune complex-mediated infl ammation. Br J Pharmacol 144:265-274.
49. Norman MU, Van De Velde N, Timoshanko JR, Issekutz A, Hickey MJ. (2003). Overlapping roles of endothelial selectins and VCAM-1 in immune complex-induced leukocyte recruitment in the cremasteric microvasculature. Am J Pathol 163:1491-1503.
50. Onodera S, Tanji H, Suzuki K, Kaneda K, Mizue YU, Sagawa A, et al. (1998). High expression of macrophage migration inhibitory factor in the synovial tissues of rheumatism joints. Cytokine 11:163-167.
51. Pan J, Sukhova GK, Yang J, Wang B, Xie T, Fu H, et al. (2004). Macrophage migration inhibitory factor defi ciency impairs atherosclerosis in low-density lipoprotein receptor-defi cient mice. Circulation 109:3149-3153.
52. Peeters BW, Ruigt GS, Craighead M, Kitchener P. (2008). Differential effects of the new glucocorticoid receptor antagonist, ORG 34517, and RU486 (mifepristone) on glucocorticoid receptor nuclear translocation in the AtT20 cell line. Ann N Y Acad Sci 1148:536-541.
53. Powell ND, Papenfuss TL, McClain MA, Gienapp IE, Shawler TM, Satoskar AR, et al. (2005). Cutting edge: macrophage migration inhibitory factor is necessary for progression of experimental autoimmune encephalomyelitis. J Immunol 175:5611-5614.
54. Roebuck KA, Finnegan A. (1999). Regulation of intercellular adhesion molecule-1 (CD54) gene transcription. J Leukoc Biol 66:876-888.
55. Roger T, Chanson A, Knaup-Reymond M, Calandra T. (2005). Macrophage migration inhibitory factor promotes innate immune responses by supressing glucocorticoid-induced expression of mitogen-activated protein kinase phosphatase-1. Eur J Immunol 35:3405-3413.
56. Rovai LE, Herschman HR, Smith JB. (1998). The murine neutrophil- chemoattractant chemokines, LIX, KC, and MIP-2, have distinct induction kinetics, tissue distributions, and tissue-specifi c sensitivities to glucocorticoid regulation in endotoxemia. J Leukoc Biol 64:494-502.
57. Santos L, Hall C, Metz CN, Bucala R, Morand E F. (2001). Role of macrophage migration inhibitory factor (MIF) in murine antigen-induced arthritis: interactions with glucocorticoids. Clin Exp Immunol 123:309-314.
58. Santos L, Lacey D, Yang Y, Leech M, Morand EF. (2004). Activation of synovial cell p38 MAP kinase by macrophage migration inhibitory factor. J Rheumatol 31:1038-1043.
59. Schramm R, Schaefer T, Menger MD, Thorlacius H. (2002). Acute mast cell-dependent neutrophil recruitment in the skin is mediated by KC and LFA-1: inhibitory mechanisms of dexamethasone. J Leukoc Biol 72:1122-1132.
60. Suzuki H, Zweifach BW, Forrest MJ, Schmid-Schonbein G W. (1995). Modifi cation of leukocyte adhesion in spontaneously hypertensive rats by adrenal corticosteroids. J Leukoc Biol 57:20-26.
61. Tailor A, Tomlinson A, Salas A, Panes J, Granger DN, Flower RJ, et al. (1999). Dexamethasone inhibition of leucocyte adhesion to rat mesenteric postcapillary venules: role of intercellular adhesion molecule 1 and KC. Gut 45:705-712.
62. Tessier P, Cattaruzzi P, McColl SR. (1996). Inhibition of lymphocyte adhesion to cytokine-activated synovial fi broblasts by glucocorticoids involves the attenuation of vascular cell adhesion molecule 1 and intercellular adhesion molecule 1 gene expression. Arthr Rheum 39:226-234.
63. Wang F, Gao F, Jing L. (2005). Is macrophage migration inhibitory factor (MIF) the "control point" of vascular hyporesponsiveness in septic shock?. Med Hypoth 65:1082-1087.
64. Weber C, Kraemer S, Dreschler M, Lue H, Koenen RR, Kapurniotu A, et al. (2008). Structural determinants of MIF functions in CXCR2-mediated infl ammatory and atherogenic leukocyte recruitment. Proc Natl Acad Sci U S A 105:16278-16283.
65. Weber KS, Draude G, Erl W, de Martin R, Weber C. (1999). Monocyte arrest and transmigration on infl amed endothelium in shear fl ow is inhibited by adenovirus-mediated gene transfer of IB-. Blood 93:3685-3693.
66. Willis MS, Carlson DL, DiMaio JM, White MD, White DJ, Adams GA, et al. (2004). Macrophage migration inhibitory factor mediates late cardiac dysfunction after burn injury. Am J Physiol 288:H795-H804.
67. Zentay Z, Sharaf M, Qadir M, Drafta D, Davidson D. (1999). Mechanism for dexamethasone inhibition of neutrophil migration upon exposure to lipopolysaccharide in vitro: role of neutrophil interleukin-8 release. Pediatr Res 46:406-410